Loading…

Arsenic toxicity manifesting as profuse watery diarrhea during induction therapy for acute promyelocytic leukemia

Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the setting of obesity and acute kidney injury. Future studies evaluating ATO levels in patients experiencing toxicities may...

Full description

Saved in:
Bibliographic Details
Published in:Clinical case reports 2021-05, Vol.9 (5), p.e04115-n/a
Main Authors: Ott, Ashley, Venkataraman, Vinayak, Badran, Yousef R., Goldman, Rose, Spasic, Smiljana, Vyas, Darshali A., Amrein, Philip, McAfee, Steven, Brunner, Andrew, Fathi, Amir T., Narayan, Rupa
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5715-86c68147aeb1cb32705887215b525e8378d26234608bf4851c3c4e231580f1953
cites cdi_FETCH-LOGICAL-c5715-86c68147aeb1cb32705887215b525e8378d26234608bf4851c3c4e231580f1953
container_end_page n/a
container_issue 5
container_start_page e04115
container_title Clinical case reports
container_volume 9
creator Ott, Ashley
Venkataraman, Vinayak
Badran, Yousef R.
Goldman, Rose
Spasic, Smiljana
Vyas, Darshali A.
Amrein, Philip
McAfee, Steven
Brunner, Andrew
Fathi, Amir T.
Narayan, Rupa
description Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the setting of obesity and acute kidney injury. Future studies evaluating ATO levels in patients experiencing toxicities may help guide dose modifications. Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the setting of obesity and acute kidney injury. Future studies evaluating ATO levels in patients experiencing toxicities may help guide dose modifications.
doi_str_mv 10.1002/ccr3.4115
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_494d082f35284bb09e1061365acbe062</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_494d082f35284bb09e1061365acbe062</doaj_id><sourcerecordid>2536756538</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5715-86c68147aeb1cb32705887215b525e8378d26234608bf4851c3c4e231580f1953</originalsourceid><addsrcrecordid>eNp9kk1r3DAQhkVpacI2h_6BIuiph01GHyNrL4Ww9CMQKJT2LGR5vKut19rIdlL_-9rZNCSH9iQhPXpmRryMvRVwLgDkRQhZnWsh8AU7lYCwhBXol0_2J-ys63YAIKCQKOA1O1EapBGIp-zmMnfUxsD79DuG2I9879tYU9fHdsN9xw851UNH_M73lEdeRZ_zljyvhjwTsa2G0MfU8n5L2R9GXqfMfRh6mp_uR2pSGPupQEPDL9pH_4a9qn3T0dnDumA_P3_6sf66vP725Wp9eb0MWAhcWhOMFbrwVIpQKlkAWltIgSVKJKsKW0kjlTZgy1pbFEEFTVIJtFCLFaoFuzp6q-R37pDj3ufRJR_d_UHKG-fz1FhDTq90BVbWCqXVZQkrEmCEMuhDSTBVWbCPR9dhKPdUBWr77Jtn0uc3bdy6Tbp1VkgphZ0E7x8EOd0M0--6XRpyO83vJOI0lpG6-D-lTIEG1ez6cKRCTl2XqX7sQ4CbI-HmSLg5EhP77mnjj-TfAEzAxRG4iw2N_za59fq7ulf-AQ1_v2U</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2536756538</pqid></control><display><type>article</type><title>Arsenic toxicity manifesting as profuse watery diarrhea during induction therapy for acute promyelocytic leukemia</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><source>Coronavirus Research Database</source><source>Wiley-Blackwell Open Access Titles(OpenAccess)</source><creator>Ott, Ashley ; Venkataraman, Vinayak ; Badran, Yousef R. ; Goldman, Rose ; Spasic, Smiljana ; Vyas, Darshali A. ; Amrein, Philip ; McAfee, Steven ; Brunner, Andrew ; Fathi, Amir T. ; Narayan, Rupa</creator><creatorcontrib>Ott, Ashley ; Venkataraman, Vinayak ; Badran, Yousef R. ; Goldman, Rose ; Spasic, Smiljana ; Vyas, Darshali A. ; Amrein, Philip ; McAfee, Steven ; Brunner, Andrew ; Fathi, Amir T. ; Narayan, Rupa</creatorcontrib><description>Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the setting of obesity and acute kidney injury. Future studies evaluating ATO levels in patients experiencing toxicities may help guide dose modifications. Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the setting of obesity and acute kidney injury. Future studies evaluating ATO levels in patients experiencing toxicities may help guide dose modifications.</description><identifier>ISSN: 2050-0904</identifier><identifier>EISSN: 2050-0904</identifier><identifier>DOI: 10.1002/ccr3.4115</identifier><identifier>PMID: 34026155</identifier><language>eng</language><publisher>England: John Wiley &amp; Sons, Inc</publisher><subject>Abdomen ; Antibiotics ; APL ; APML ; Arsenic ; Blood ; Cardiac arrhythmia ; Case Report ; Case Reports ; Creatinine ; Diarrhea ; Drug dosages ; Induction therapy ; Leukemia ; Metabolites ; Nausea ; obesity ; Pancreatitis ; Patients ; Peripheral neuropathy ; Poisoning ; renal insufficiency ; Severe acute respiratory syndrome coronavirus 2 ; Toxicity ; Urine ; Vomiting</subject><ispartof>Clinical case reports, 2021-05, Vol.9 (5), p.e04115-n/a</ispartof><rights>2021 The Authors. published by John Wiley &amp; Sons Ltd.</rights><rights>2021 The Authors. Clinical Case Reports published by John Wiley &amp; Sons Ltd.</rights><rights>2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5715-86c68147aeb1cb32705887215b525e8378d26234608bf4851c3c4e231580f1953</citedby><cites>FETCH-LOGICAL-c5715-86c68147aeb1cb32705887215b525e8378d26234608bf4851c3c4e231580f1953</cites><orcidid>0000-0002-4675-6503</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2557216247/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2557216247?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,11562,25753,27924,27925,37012,38516,43895,44590,46052,46476,53791,53793,74412,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34026155$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ott, Ashley</creatorcontrib><creatorcontrib>Venkataraman, Vinayak</creatorcontrib><creatorcontrib>Badran, Yousef R.</creatorcontrib><creatorcontrib>Goldman, Rose</creatorcontrib><creatorcontrib>Spasic, Smiljana</creatorcontrib><creatorcontrib>Vyas, Darshali A.</creatorcontrib><creatorcontrib>Amrein, Philip</creatorcontrib><creatorcontrib>McAfee, Steven</creatorcontrib><creatorcontrib>Brunner, Andrew</creatorcontrib><creatorcontrib>Fathi, Amir T.</creatorcontrib><creatorcontrib>Narayan, Rupa</creatorcontrib><title>Arsenic toxicity manifesting as profuse watery diarrhea during induction therapy for acute promyelocytic leukemia</title><title>Clinical case reports</title><addtitle>Clin Case Rep</addtitle><description>Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the setting of obesity and acute kidney injury. Future studies evaluating ATO levels in patients experiencing toxicities may help guide dose modifications. Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the setting of obesity and acute kidney injury. Future studies evaluating ATO levels in patients experiencing toxicities may help guide dose modifications.</description><subject>Abdomen</subject><subject>Antibiotics</subject><subject>APL</subject><subject>APML</subject><subject>Arsenic</subject><subject>Blood</subject><subject>Cardiac arrhythmia</subject><subject>Case Report</subject><subject>Case Reports</subject><subject>Creatinine</subject><subject>Diarrhea</subject><subject>Drug dosages</subject><subject>Induction therapy</subject><subject>Leukemia</subject><subject>Metabolites</subject><subject>Nausea</subject><subject>obesity</subject><subject>Pancreatitis</subject><subject>Patients</subject><subject>Peripheral neuropathy</subject><subject>Poisoning</subject><subject>renal insufficiency</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Toxicity</subject><subject>Urine</subject><subject>Vomiting</subject><issn>2050-0904</issn><issn>2050-0904</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kk1r3DAQhkVpacI2h_6BIuiph01GHyNrL4Ww9CMQKJT2LGR5vKut19rIdlL_-9rZNCSH9iQhPXpmRryMvRVwLgDkRQhZnWsh8AU7lYCwhBXol0_2J-ys63YAIKCQKOA1O1EapBGIp-zmMnfUxsD79DuG2I9879tYU9fHdsN9xw851UNH_M73lEdeRZ_zljyvhjwTsa2G0MfU8n5L2R9GXqfMfRh6mp_uR2pSGPupQEPDL9pH_4a9qn3T0dnDumA_P3_6sf66vP725Wp9eb0MWAhcWhOMFbrwVIpQKlkAWltIgSVKJKsKW0kjlTZgy1pbFEEFTVIJtFCLFaoFuzp6q-R37pDj3ufRJR_d_UHKG-fz1FhDTq90BVbWCqXVZQkrEmCEMuhDSTBVWbCPR9dhKPdUBWr77Jtn0uc3bdy6Tbp1VkgphZ0E7x8EOd0M0--6XRpyO83vJOI0lpG6-D-lTIEG1ez6cKRCTl2XqX7sQ4CbI-HmSLg5EhP77mnjj-TfAEzAxRG4iw2N_za59fq7ulf-AQ1_v2U</recordid><startdate>202105</startdate><enddate>202105</enddate><creator>Ott, Ashley</creator><creator>Venkataraman, Vinayak</creator><creator>Badran, Yousef R.</creator><creator>Goldman, Rose</creator><creator>Spasic, Smiljana</creator><creator>Vyas, Darshali A.</creator><creator>Amrein, Philip</creator><creator>McAfee, Steven</creator><creator>Brunner, Andrew</creator><creator>Fathi, Amir T.</creator><creator>Narayan, Rupa</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><general>Wiley</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-4675-6503</orcidid></search><sort><creationdate>202105</creationdate><title>Arsenic toxicity manifesting as profuse watery diarrhea during induction therapy for acute promyelocytic leukemia</title><author>Ott, Ashley ; Venkataraman, Vinayak ; Badran, Yousef R. ; Goldman, Rose ; Spasic, Smiljana ; Vyas, Darshali A. ; Amrein, Philip ; McAfee, Steven ; Brunner, Andrew ; Fathi, Amir T. ; Narayan, Rupa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5715-86c68147aeb1cb32705887215b525e8378d26234608bf4851c3c4e231580f1953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Abdomen</topic><topic>Antibiotics</topic><topic>APL</topic><topic>APML</topic><topic>Arsenic</topic><topic>Blood</topic><topic>Cardiac arrhythmia</topic><topic>Case Report</topic><topic>Case Reports</topic><topic>Creatinine</topic><topic>Diarrhea</topic><topic>Drug dosages</topic><topic>Induction therapy</topic><topic>Leukemia</topic><topic>Metabolites</topic><topic>Nausea</topic><topic>obesity</topic><topic>Pancreatitis</topic><topic>Patients</topic><topic>Peripheral neuropathy</topic><topic>Poisoning</topic><topic>renal insufficiency</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Toxicity</topic><topic>Urine</topic><topic>Vomiting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ott, Ashley</creatorcontrib><creatorcontrib>Venkataraman, Vinayak</creatorcontrib><creatorcontrib>Badran, Yousef R.</creatorcontrib><creatorcontrib>Goldman, Rose</creatorcontrib><creatorcontrib>Spasic, Smiljana</creatorcontrib><creatorcontrib>Vyas, Darshali A.</creatorcontrib><creatorcontrib>Amrein, Philip</creatorcontrib><creatorcontrib>McAfee, Steven</creatorcontrib><creatorcontrib>Brunner, Andrew</creatorcontrib><creatorcontrib>Fathi, Amir T.</creatorcontrib><creatorcontrib>Narayan, Rupa</creatorcontrib><collection>Wiley-Blackwell Open Access Titles(OpenAccess)</collection><collection>Wiley-Blackwell Open Access Backfiles (Open Access)</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Complete (ProQuest Database)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Clinical case reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ott, Ashley</au><au>Venkataraman, Vinayak</au><au>Badran, Yousef R.</au><au>Goldman, Rose</au><au>Spasic, Smiljana</au><au>Vyas, Darshali A.</au><au>Amrein, Philip</au><au>McAfee, Steven</au><au>Brunner, Andrew</au><au>Fathi, Amir T.</au><au>Narayan, Rupa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Arsenic toxicity manifesting as profuse watery diarrhea during induction therapy for acute promyelocytic leukemia</atitle><jtitle>Clinical case reports</jtitle><addtitle>Clin Case Rep</addtitle><date>2021-05</date><risdate>2021</risdate><volume>9</volume><issue>5</issue><spage>e04115</spage><epage>n/a</epage><pages>e04115-n/a</pages><issn>2050-0904</issn><eissn>2050-0904</eissn><abstract>Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the setting of obesity and acute kidney injury. Future studies evaluating ATO levels in patients experiencing toxicities may help guide dose modifications. Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the setting of obesity and acute kidney injury. Future studies evaluating ATO levels in patients experiencing toxicities may help guide dose modifications.</abstract><cop>England</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>34026155</pmid><doi>10.1002/ccr3.4115</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-4675-6503</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2050-0904
ispartof Clinical case reports, 2021-05, Vol.9 (5), p.e04115-n/a
issn 2050-0904
2050-0904
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_494d082f35284bb09e1061365acbe062
source Open Access: PubMed Central; Publicly Available Content Database; Coronavirus Research Database; Wiley-Blackwell Open Access Titles(OpenAccess)
subjects Abdomen
Antibiotics
APL
APML
Arsenic
Blood
Cardiac arrhythmia
Case Report
Case Reports
Creatinine
Diarrhea
Drug dosages
Induction therapy
Leukemia
Metabolites
Nausea
obesity
Pancreatitis
Patients
Peripheral neuropathy
Poisoning
renal insufficiency
Severe acute respiratory syndrome coronavirus 2
Toxicity
Urine
Vomiting
title Arsenic toxicity manifesting as profuse watery diarrhea during induction therapy for acute promyelocytic leukemia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T10%3A24%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Arsenic%20toxicity%20manifesting%20as%20profuse%20watery%20diarrhea%20during%20induction%20therapy%20for%20acute%20promyelocytic%20leukemia&rft.jtitle=Clinical%20case%20reports&rft.au=Ott,%20Ashley&rft.date=2021-05&rft.volume=9&rft.issue=5&rft.spage=e04115&rft.epage=n/a&rft.pages=e04115-n/a&rft.issn=2050-0904&rft.eissn=2050-0904&rft_id=info:doi/10.1002/ccr3.4115&rft_dat=%3Cproquest_doaj_%3E2536756538%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5715-86c68147aeb1cb32705887215b525e8378d26234608bf4851c3c4e231580f1953%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2536756538&rft_id=info:pmid/34026155&rfr_iscdi=true